Functional impact of multi-omic interactions in lung cancer

被引:0
|
作者
Diaz-Campos, Miguel Angel [1 ]
Vasquez-Arriaga, Jorge [1 ]
Ochoa, Soledad [1 ,2 ]
Hernandez-Lemus, Enrique [1 ,3 ]
机构
[1] Natl Inst Genom Med, Computat Genom Div, Mexico City, Mexico
[2] Cedars Sinai Med Ctr, Dept Obstet & Gynecol, Los Angeles, CA USA
[3] Univ Nacl Autonoma Mexico, Ctr Complex Sci, Mexico City, Mexico
关键词
lung adenocarcinoma; lung squamous cell carcinoma; multiomics; mutual information; network construction; computational analysis; RIBOSOMAL-PROTEIN S6; DOWN-REGULATION; R PACKAGE; METHYLATION; EXPRESSION; RNA; PROLIFERATION; CENTRALITY; MIR-125B; GROWTH;
D O I
10.3389/fgene.2024.1282241
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Lung tumors are a leading cause of cancer-related death worldwide. Lung cancers are highly heterogeneous on their phenotypes, both at the cellular and molecular levels. Efforts to better understand the biological origins and outcomes of lung cancer in terms of this enormous variability often require of high-throughput experimental techniques paired with advanced data analytics. Anticipated advancements in multi-omic methodologies hold potential to reveal a broader molecular perspective of these tumors. This study introduces a theoretical and computational framework for generating network models depicting regulatory constraints on biological functions in a semi-automated way. The approach successfully identifies enriched functions in analyzed omics data, focusing on Adenocarcinoma (LUAD) and Squamous cell carcinoma (LUSC, a type of NSCLC) in the lung. Valuable information about novel regulatory characteristics, supported by robust biological reasoning, is illustrated, for instance by considering the role of genes, miRNAs and CpG sites associated with NSCLC, both novel and previously reported. Utilizing multi-omic regulatory networks, we constructed robust models elucidating omics data interconnectedness, enabling systematic generation of mechanistic hypotheses. These findings offer insights into complex regulatory mechanisms underlying these cancer types, paving the way for further exploring their molecular complexity.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Editorial: Multi-omic data integration
    Nardini, Christine
    Dent, Jennifer
    Tieri, Paolo
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2015, 3
  • [32] Multi-omic analyses of lung cancer tumors show role of AKT and MYC as regulators of lung adenocarcinoma to squamous cell lung cancer transdifferentiation
    Sen, T.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S137 - S137
  • [33] A multi-omic future for microbiome studies
    Jansson, Janet K.
    Baker, Erin S.
    NATURE MICROBIOLOGY, 2016, 1 (05)
  • [34] Cardiotoxicity of Chemotherapy: A Multi-OMIC Perspective
    Ma, Yan
    Grootaert, Mandy O. J.
    Sewduth, Raj N.
    JOURNAL OF XENOBIOTICS, 2025, 15 (01)
  • [35] A multi-omic resource of mouse neutrophils
    Alexandra Le Bras
    Lab Animal, 2021, 50 : 239 - 239
  • [36] MULTI-OMIC RISK PREDICTION FOR CHOLANGIOCARCINOMA
    Van Haag, Felix
    Clusmann, Jan
    Koop, Paul-Henry
    Schneider, Kai Markus
    Schneider, Carolin Victoria
    HEPATOLOGY, 2024, 80
  • [37] Multi-omic dissection of immunotherapy response groups in non-small cell lung cancer (NSCLC)
    Kulasinghe, Arutha
    Monkman, James
    Kim, Honesty
    Mayer, Aaron
    Mehdi, Ahmed
    Matigian, Nicholas
    Cumberbatch, Marie
    Bhagat, Milan
    Ladwa, Rahul
    Mueller, Scott
    Adams, Mark
    O'Byrne, Ken
    CANCER RESEARCH, 2022, 82 (12)
  • [38] Multi-omic and multi-view clustering algorithms: review and cancer benchmark
    Rappoport, Nimrod
    Shamir, Ron
    NUCLEIC ACIDS RESEARCH, 2018, 46 (20) : 10546 - 10562
  • [39] Multi-omic and spatial dissection of immunotherapy response groups in non-small cell lung cancer
    Monkman, James
    Kim, Honesty
    Mayer, Aaron
    Mehdi, Ahmed
    Matigian, Nicholas
    Cumberbatch, Marie
    Bhagat, Milan
    Ladwa, Rahul
    Mueller, Scott N.
    Adams, Mark N.
    O'Byrne, Ken
    Kulasinghe, Arutha
    IMMUNOLOGY, 2023, 169 (04) : 487 - 502
  • [40] MULTI-OMIC CHARACTERIZATION OF LUNG CANCER BRAIN METASTASIS REVEALS THE METABOLIC VULNERABILITY AS A NOVEL THERAPEUTIC TARGET
    Duan, H.
    Wei, S.
    Liu, Y.
    Zhang, G.
    Mou, Y.
    NEURO-ONCOLOGY, 2023, 25